GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sol-Gel Technologies Ltd (NAS:SLGL) » Definitions » Valuation Rank

Sol-Gel Technologies (Sol-Gel Technologies) Valuation Rank


View and export this data going back to 2018. Start your Free Trial

What is Sol-Gel Technologies Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Sol-Gel Technologies Valuation Rank Related Terms

Thank you for viewing the detailed overview of Sol-Gel Technologies's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Sol-Gel Technologies (Sol-Gel Technologies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sol-Gel Technologies Ltd (NAS:SLGL) » Definitions » Valuation Rank
Comparable Companies
VTVT DTIL BSEM HOOK INKT GANX ELDN PASG BOLT LPTX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
4SG:Germany 4SG:Germany
Address
7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Website
https://www.sol-gel.com
Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.